Literature DB >> 9321846

Melatonin directly constricts rat cerebral arteries through modulation of potassium channels.

G G Geary1, D N Krause, S P Duckles.   

Abstract

The pineal hormone melatonin was found to decrease luminal diameter of rat middle cerebral artery segments, pressurized in vitro, in a concentration-dependent manner (concentration that produced a half-maximal effect = 2.7 nM). Contractile responses to melatonin were inhibited by luzindole, a melatonin receptor antagonist, but not by the serotonin receptor antagonist ketanserin. Pertussis toxin abolished the effect of melatonin, which is consistent with involvement of Gi or G(o) protein-coupled receptors. The maximal effect of melatonin was increased by elevating transmural pressure. When compared at the same pressure, contractions elicited by melatonin were smaller than those elicited by serotonin but similar in magnitude to those produced by tetraethylammonium or charybdotoxin, blockers of Ca(2+)-dependent, large-conductance K+ (BKCa) channels. The effect of melatonin was significantly attenuated in the presence of BKCa channel blockers, but not by apamin, a blocker of Ca(2+)-dependent, small-conductance K+ channels. Melatonin, like tetraethylammonium, significantly reduced vasodilation produced by NS-1619, an opener of BKCa channels. Contractile responses to melatonin were diminished in the presence of elevated extracellular K+ (16 mM), but they were not significantly affected by NG-nitro-L-arginine methyl ester. The results suggest that activation of melatonin receptors on rat cerebral arteries increases vascular tone through Gi or G(o) protein-mediated inhibition of BKCa channels. Thus melatonin, which is secreted during the night, can directly influence the contractile state of cerebral arteries.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9321846     DOI: 10.1152/ajpheart.1997.273.3.H1530

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  16 in total

1.  Apelin Reduces Nitric Oxide-Induced Relaxation of Cerebral Arteries by Inhibiting Activation of Large-Conductance, Calcium-Activated K Channels.

Authors:  Amreen Mughal; Chengwen Sun; Stephen T OʼRourke
Journal:  J Cardiovasc Pharmacol       Date:  2018-04       Impact factor: 3.105

2.  Effects of melatonin on rat pial arteriolar diameter in vivo.

Authors:  O Régrigny; P Delagrange; E Scalbert; I Lartaud-Idjouadiene; J Atkinson; J M Chillon
Journal:  Br J Pharmacol       Date:  1999-08       Impact factor: 8.739

3.  Melatonin differentially affects vascular blood flow in humans.

Authors:  Jonathan S Cook; Charity L Sauder; Chester A Ray
Journal:  Am J Physiol Heart Circ Physiol       Date:  2010-12-10       Impact factor: 4.733

4.  International Union of Basic and Clinical Pharmacology. LXXV. Nomenclature, classification, and pharmacology of G protein-coupled melatonin receptors.

Authors:  Margarita L Dubocovich; Philippe Delagrange; Diana N Krause; David Sugden; Daniel P Cardinali; James Olcese
Journal:  Pharmacol Rev       Date:  2010-07-06       Impact factor: 25.468

5.  The putative melatonin receptor antagonist GR128107 is a partial agonist on Xenopus laevis melanophores.

Authors:  M T Teh; D Sugden
Journal:  Br J Pharmacol       Date:  1999-03       Impact factor: 8.739

6.  Melatonin inhibits nitrate tolerance in isolated coronary arteries.

Authors:  Stephen T O'Rourke; Hana Hammad; Philippe Delagrange; Elizabeth Scalbert; Paul M Vanhoutte
Journal:  Br J Pharmacol       Date:  2003-08       Impact factor: 8.739

7.  Dose-dependent dual effect of melatonin on ototoxicity induced by amikacin in adult rats.

Authors:  Tamer Erdem; Orhan Ozturan; Mustafa Iraz; Murat Cem Miman; Ercument Olmez
Journal:  Eur Arch Otorhinolaryngol       Date:  2004-05-28       Impact factor: 2.503

Review 8.  Melatonin receptors, heterodimerization, signal transduction and binding sites: what's new?

Authors:  R Jockers; P Maurice; J A Boutin; P Delagrange
Journal:  Br J Pharmacol       Date:  2008-05-19       Impact factor: 8.739

9.  Partial neural protection with prophylactic low-dose melatonin after asphyxia in preterm fetal sheep.

Authors:  Paul P Drury; Joanne O Davidson; Laura Bennet; Lindsea C Booth; Sidhartha Tan; Mhoyra Fraser; Lotte G van den Heuij; Alistair J Gunn
Journal:  J Cereb Blood Flow Metab       Date:  2013-10-09       Impact factor: 6.200

10.  Impact of treatment with melatonin on cerebral circulation in old rats.

Authors:  François Dupuis; Olivier Régrigny; Jeffrey Atkinson; Patrick Limiñana; Philippe Delagrange; Elizabeth Scalbert; Jean-Marc Chillon
Journal:  Br J Pharmacol       Date:  2004-01-12       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.